Tuesday, November 01, 2022 9:59:19 AM
Thanks goes out to the market makers that shorted yesterday giving a better entry point today.
Recent SONN News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/03/2025 05:15:13 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/31/2025 09:57:21 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/31/2025 09:56:21 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/30/2025 10:25:42 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 01/30/2025 10:25:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/28/2025 02:10:11 PM
- Sonnet BioTherapeutics Further Expands Global Intellectual Property Portfolio with Issuance of EU Patent for FHAB® Platform Technology • GlobeNewswire Inc. • 01/28/2025 02:05:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/22/2025 09:15:46 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 01/22/2025 09:11:14 PM
- Sonnet BioTherapeutics to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar • GlobeNewswire Inc. • 01/22/2025 01:35:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/21/2025 02:17:30 PM
- Sonnet BioTherapeutics Expands Phase 1 SB101 Trial to Evaluate Combination of SON-1010 with Trabectedin in Certain Sarcomas • GlobeNewswire Inc. • 01/21/2025 02:05:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 01/21/2025 01:30:32 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 01/13/2025 09:34:28 PM
- Sonnet BioTherapeutics Announces Release of the Next CEO Corner Segment • GlobeNewswire Inc. • 12/23/2024 02:20:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 12/17/2024 02:00:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/17/2024 01:50:19 PM
- Sonnet BioTherapeutics Reports Fiscal Year 2024 Financial Results and Provides Corporate Update • GlobeNewswire Inc. • 12/17/2024 01:50:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/10/2024 02:25:12 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/10/2024 02:20:37 PM
- Sonnet BioTherapeutics Announces $3.9 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 12/09/2024 08:42:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/09/2024 01:50:14 PM
HealthLynked Corp. Releases Annual Shareholder Letter Highlighting Recent Product Development and Strategic Vision for the Future • HLYK • Feb 4, 2025 8:00 AM
Wytec Wins Multi-State Government Contract for AI Gunshot Detection • WYTC • Feb 3, 2025 7:16 AM
UAV Corp. Retains Legal Counsel to Address Legacy Debt from HTTI Era; 500 Million Authorized Shares Confirmed - UAV Corp. Delivers on Strategic Commitments • UMAV • Jan 31, 2025 1:30 PM
VAYK Closes Acquisition of $1 Million Company • VAYK • Jan 30, 2025 9:52 AM
C2 Blockchain Inc. Secures Regulation A Approval, Prepares to Launch Bitcoin Mining Operations • CBLO • Jan 30, 2025 8:00 AM
Swifty Global Announces Signing of Share Purchase Agreement to be Acquired by Signing Day Sport (NYSE AMERICAN: SGN) • DRCR • Jan 29, 2025 11:19 AM